Pfizer could be just a few months away from getting FDA approval for its JAK1 inhibitor abrocitinib in atopic dermatitis, a drug that CEO Albert Bourla believes hasn’t been given the credit it ...

Abrocitinib is under clinical development by Pfizer and currently in Phase II for Dermatological Disorders. According to GlobalData, Phase II drugs for Dermatological Disorders have a 20% phase ...

There are already several JAK inhibitors on the market – including Pfizer's own Xeljanz (abrocitinib) – while the TYK2 category is being led by Bristol-Myers Squibb's deucravacitinib ...

With Staquis and Cibinqo, Pfizer is empowering patients with effective options ... Simpson EL, Sinclair R, Forman S, et al. Efficacy and safety of abrocitinib in adults and adolescents with ...

In a similar manner, Spain's Ministry of Health (MoH) proposed that Pfizer's atopic dermatitis treatment Cibinqo (abrocitinib) is equivalent to Almirall's Ebglyss. This news was a surprise to ...

In a similar manner, Spain’s Ministry of Health (MoH) proposed that Pfizer’s atopic dermatitis treatment Cibinqo (abrocitinib) is equivalent to Almirall’s Ebglyss. This news was a surprise to Almirall ...

NEW YORK, Feb 3 (Reuters) - Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could put additional pressure on Pfizer (PFE.N ...

While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I think we did significant transformative changes in Pfizer.” ...

Pfizer saved $4 billion, plans $1.5 billion more in margin improvements, and issued $7 billion in dividends in nine months. Acquisitions are projected to offset $17 billion-18 billion in revenue ...

Jan 13 (Reuters) - U.S. drugmaker Pfizer (PFE.N), opens new tab is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Executive ...

However, at least two conditions listed as adverse events also appeared in Pfizer's 2024 list of genuine side effects. In January 2025, Snopes readers asked us about the authenticity of a long ...

Pfizer PFE-0.49%decrease; red down pointing triangle has sold 700 million shares in British consumer-healthcare business Haleon HLN-0.95%decrease; red down pointing triangle for 2.50 billion ...